On May 27, 2025 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") reported that members of its executive team will present and host 1×1 meetings at the upcoming investor conferences, detailed below (Press release, Innate Pharma, MAY 27, 2025, View Source [SID1234653399]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

•Jefferies Global Healthcare Conference
Dates: June 3 – 5 2025 | New-York, USA

The executive team will participate in a fireside chat scheduled on Thursday June 5, 2025, from 7:35 to 8:05 am EDT.

•Goldman Sachs 46th Annual Global Healthcare Conference
Dates: June 9 – 11 2025 | Miami, USA

The executive team will participate in a fireside chat scheduled on Tuesday June 10 2025, from 4:00 to 4:35 pm EDT.

In addition, members of the executive team will participate and represent the Company during the 2025 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Annual Meeting being held from May 30 to June 3, 2025 in Chicago, Illinois.